Stevenage bioscience hub

Located amid a cluster of academic centres of excellence and other pharma companies, the Stevenage Bioscience Catalyst campus is a major hub for early-stage biotechnology companies. It provides small to medium-sized biotech and life sciences companies and start-ups with access to the expertise, networks and scientific facilities traditionally associated with multinational pharmaceutical companies.

A key aim of Stevenage Bioscience Catalyst is to pioneer a culture of open-innovation that will place the UK bioscience sector at the forefront of worldwide biomedical discovery and deliver cutting edge healthcare solutions.

Our involvement

The Stevenage campus is the result of a unique partnership between GSK, the Department of Business, Innovation & Skills, the Wellcome Trust, the East of England Development Agency and the Technology Strategy Board. GSK provided land, facilities and investment totalling almost £11m to help build and launch the campus.

The campus opened for business on 9 February 2012 and welcomed its first tenant – Aptiv Solutions – on the same day.

Facilities and opportunities

With long-term plans to expand the campus fivefold, the Stevenage Bioscience Catalyst campus offers a range of equipment and commercial opportunities that would be impossible for a small or medium-sized enterprise (SME) to develop alone.

In addition to its outstanding scientific facilities, Stevenage Bioscience Catalyst also offers valuable opportunities for scientific and commercial networking. Tenants retain full independence and the freedom to interact with any commercial partners.

For more information visit the Stevenage Bioscience Catalyst website